{"pmid":32499304,"title":"One world, one pandemic, many guidelines: management of liver diseases during COVID-19.","text":["One world, one pandemic, many guidelines: management of liver diseases during COVID-19.","Gut","Bollipo, Steven","Kapuria, Devika","Rabiee, Atoosa","Ben-Yakov, Gil","Lui, Rashid N","Lee, Hye Won","Kumar, Goutham","Siau, Keith","Turnes, Juan","Dhanasekaran, Renumathy","32499304"],"journal":"Gut","authors":["Bollipo, Steven","Kapuria, Devika","Rabiee, Atoosa","Ben-Yakov, Gil","Lui, Rashid N","Lee, Hye Won","Kumar, Goutham","Siau, Keith","Turnes, Juan","Dhanasekaran, Renumathy"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499304","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/gutjnl-2020-321553","keywords":["hepatobiliary disease","hepatocellular carcinoma","infectious disease","liver cirrhosis","liver transplantation"],"topics":["Prevention"],"weight":1,"_version_":1668890966298198016,"score":9.490897,"similar":[{"pmid":32434831,"title":"Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.","text":["Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.","Gut","Qi, Xiaolong","Liu, Yanna","Wang, Jitao","Fallowfield, Jonathan","Wang, Jianwen","Li, Xinyu","Shi, Jindong","Pan, Hongqiu","Zou, Shengqiang","Zhang, Hongguang","Chen, Zhenhuai","Li, Fujian","Luo, Yan","Mei, Mei","Liu, Huiling","Wang, Zhengyan","Li, Jinlin","Yang, Hua","Xiang, Huihua","Li, Xiaodan","Liu, Tao","Zheng, Ming-Hua","Liu, Chuan","Huang, Yifei","Xu, Dan","Li, Xiaoguo","Kang, Ning","He, Qing","Gu, Ye","Zhang, Guo","Shao, Chuxiao","Liu, Dengxiang","Zhang, Lin","Li, Xun","Kawada, Norifumi","Jiang, Zicheng","Wang, Fengmei","Xiong, Bin","Takehara, Tetsuo","Rockey, Don C","32434831"],"journal":"Gut","authors":["Qi, Xiaolong","Liu, Yanna","Wang, Jitao","Fallowfield, Jonathan","Wang, Jianwen","Li, Xinyu","Shi, Jindong","Pan, Hongqiu","Zou, Shengqiang","Zhang, Hongguang","Chen, Zhenhuai","Li, Fujian","Luo, Yan","Mei, Mei","Liu, Huiling","Wang, Zhengyan","Li, Jinlin","Yang, Hua","Xiang, Huihua","Li, Xiaodan","Liu, Tao","Zheng, Ming-Hua","Liu, Chuan","Huang, Yifei","Xu, Dan","Li, Xiaoguo","Kang, Ning","He, Qing","Gu, Ye","Zhang, Guo","Shao, Chuxiao","Liu, Dengxiang","Zhang, Lin","Li, Xun","Kawada, Norifumi","Jiang, Zicheng","Wang, Fengmei","Xiong, Bin","Takehara, Tetsuo","Rockey, Don C"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434831","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/gutjnl-2020-321666","keywords":["infectious disease","liver cirrhosis"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667521393707712512,"score":85.60212},{"pmid":32238956,"title":"COVID-19: One world, one health.","text":["COVID-19: One world, one health.","Tidsskr Nor Laegeforen","Jorgensen, Hannah Joan","Neves, Carlos das","32238956"],"journal":"Tidsskr Nor Laegeforen","authors":["Jorgensen, Hannah Joan","Neves, Carlos das"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238956","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.4045/tidsskr.20.0212","weight":0,"_version_":1666138490279034880,"score":75.531166},{"pmid":32277387,"pmcid":"PMC7146012","title":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","text":["Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.","Hepatol Int","Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George","32277387"],"abstract":["Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic."],"journal":"Hepatol Int","authors":["Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277387","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10043-z","keywords":["2019-ncov","covid-19","liver transplantation","management"],"locations":["Beijing","China","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis","Treatment"],"weight":1,"_version_":1666138491597094912,"score":74.8118},{"pmid":32224711,"title":"COVID-19: one threat, one world, one response (magical thinking).","text":["COVID-19: one threat, one world, one response (magical thinking).","Eur J Emerg Med","Miro, Oscar","32224711"],"journal":"Eur J Emerg Med","authors":["Miro, Oscar"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32224711","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1097/MEJ.0000000000000707","weight":0,"_version_":1666138492456927234,"score":71.86802},{"pmid":32439237,"title":"Liver transplantation in the era of COVID-19.","text":["Liver transplantation in the era of COVID-19.","Liver transplantation is considered the ultimate solution for patients with end-stage chronic liver disease or acute liver failure. Patients with liver transplant need special care starting from preoperative preparation, surgical intervention ending with postoperative care. Transplanted patients have to receive immunosuppressive therapy to prevent rejection. Such a state of immune suppression could predispose to different types of infections in liver transplant recipients. Currently, the world is suffering a pandemic caused by a new strain of the coronavirus family called COVID-19. Certain infection control precautions are needed to protect immunocompromised and vulnerable patients, including liver transplant candidates and recipients from acquiring COVID-19 infection. Restricting non-transplant elective surgical procedures, managing transplant patients in separate outpatient clinics, and in-patient wards can prevent transmission of infection both to patients and healthcare workers. Telemedicine can help in the triage of patients to screen for symptoms of COVID-19 before their regular appointment. Management of immunosuppressive therapy and drug-drug interactions in liver transplant recipients infected with COVID-19 should be cautiously practiced to prevent rejection and effectively treat the underlying infection. In this report, we are trying to summarize available evidence about different aspects of the management of liver transplant candidates and recipients in the era of COVID-19.","Arab J Gastroenterol","El Kassas, Mohamed","Alboraie, Mohamed","Al Balakosy, Amira","Abdeen, Nermeen","Afify, Shimaa","Abdalgaber, Mohammad","Sherief, Ahmed F","Madkour, Ahmad","Abdellah Ahmed, Mohamed","Eltabbakh, Mohamed","Salaheldin, Mohamed","Wifi, Mohamed-Naguib","32439237"],"abstract":["Liver transplantation is considered the ultimate solution for patients with end-stage chronic liver disease or acute liver failure. Patients with liver transplant need special care starting from preoperative preparation, surgical intervention ending with postoperative care. Transplanted patients have to receive immunosuppressive therapy to prevent rejection. Such a state of immune suppression could predispose to different types of infections in liver transplant recipients. Currently, the world is suffering a pandemic caused by a new strain of the coronavirus family called COVID-19. Certain infection control precautions are needed to protect immunocompromised and vulnerable patients, including liver transplant candidates and recipients from acquiring COVID-19 infection. Restricting non-transplant elective surgical procedures, managing transplant patients in separate outpatient clinics, and in-patient wards can prevent transmission of infection both to patients and healthcare workers. Telemedicine can help in the triage of patients to screen for symptoms of COVID-19 before their regular appointment. Management of immunosuppressive therapy and drug-drug interactions in liver transplant recipients infected with COVID-19 should be cautiously practiced to prevent rejection and effectively treat the underlying infection. In this report, we are trying to summarize available evidence about different aspects of the management of liver transplant candidates and recipients in the era of COVID-19."],"journal":"Arab J Gastroenterol","authors":["El Kassas, Mohamed","Alboraie, Mohamed","Al Balakosy, Amira","Abdeen, Nermeen","Afify, Shimaa","Abdalgaber, Mohammad","Sherief, Ahmed F","Madkour, Ahmad","Abdellah Ahmed, Mohamed","Eltabbakh, Mohamed","Salaheldin, Mohamed","Wifi, Mohamed-Naguib"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439237","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ajg.2020.04.019","keywords":["covid-19","coronavirus","liver transplantation"],"topics":["Prevention"],"weight":1,"_version_":1667523504770121729,"score":68.27156}]}